Content
@
https://warpcast.com/~/channel/superbowl-lix
0 reply
0 recast
0 reaction
Joe Petrich 🟪
@jpetrich
https://x.com/Austen/status/1888775370385567885?t=dfN0RgIdIuzAwa2Z_XOxeA&s=19 My thoughts exactly, so disappointing 😞
3 replies
0 recast
4 reactions
keccers
@keccers.eth
Their target audience is not necessarily dissatisfied with their food options or anything else as they are the cost and accessibility of GLP-1 medications. They feel the system has failed them because they are priced out of access to innovation. Don’t even get me started on what goes on in the grey market. We can try to shame or act paternalistic towards these people, but I am unsure it will help. They want what they want and it is obesity meds. Many of these patients have already tried diets and failed. The ad was previewed and met w/ strong backlash from people who provide these drugs in their non-compounded form (ie obesity meds clinics like a16z backed knownwell) or otherwise have interest in protecting pharma IP. I believe this is the first flag in a long legal fight over compounding. Access to compounding is otherwise a huge part of “MAHA” when it doesn’t mean fat people drugs. They believe it is an anti big pharma move, broadly. https://www.facebook.com/share/v/12H2WNRKM3Q/?mibextid=wwXIfr
2 replies
0 recast
4 reactions
Ben
@benersing
@keccers.eth is spot on. Its an unfortunate indicator of the state of the average US healthcare consumer who wants better health with less work.
0 reply
0 recast
2 reactions
Metaphorical
@hyp
Gross
0 reply
0 recast
1 reaction
